Corline Biomedical AB financials at a glance

+ Portfolio

The revenue of Corline Biomedical AB is reported as 0.03 billion Kronor in the fiscal year 2023. The earnings were 0 Kronor per share in 2023, which was 100 lower than 2022. And about 0.00206 billion Kronor are reported as free cash flow in the financials of Corline Biomedical AB 2023. No dividends were paid to the shareholders of the Corline Biomedical AB stock OM:CLBIO in the financial year 2023.

kr30.00M

Revenue

kr0.00

Earnings Per Share

79.90%

Gross Margin %

kr-8.00M

Free Cash Flow

Revenue

30.00

Earnings Per Share

0.00

Gross Margin %

79.90

Free Cash Flow

-8.00

Financials

Year	Year	TTM	2023	2022	2021	2019	2018	2017	2016
Rev.	Revenue	N/A	kr30.00M	kr23.55M	kr7.06M	kr1.06M	kr1.56M	kr0.64M	kr0.95M
GM %	Gross Margin %	76.77%	79.90%	69.73%	52.94%	59.94%	68.53%	69.09%	78.57%
OM	Operating Margin	-2.30%	-5.03%	7.15%	-40.18%	-80.01%	-71.29%	-48.39%	-55.04%
EPS	Earnings Per Share	kr-0.04	kr0.00	kr0.11	kr-0.34	kr-0.59	kr-0.45	kr-0.59	kr-0.45
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	21.49M	21.49M	21.49M	16.67M	15.77M	14.56M	12.74M
OCF	Operating Cash Flow	N/A	kr3.00M	kr-6.45M	kr-4.84M	kr-13.84M	kr-4.10M	kr-4.98M	kr-7.30M
FCF	Free Cash Flow	N/A	kr-8.00M	kr-15.30M	kr-14.45M	kr-18.68M	kr-5.04M	kr-10.00M	kr-15.75M
FCFS	Free Cash Flow Per Share	kr-0.57	kr-0.45	kr-0.72	kr-0.71	kr-1.15	kr-0.33	kr-0.75	kr-1.34

Corline Biomedical AB financials at a glance

Financials

Discover